Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003533:Cyproheptadine / Q000494:pharmacology*; D003864:Depression, Chemical; D004357:Drug Synergism; D005106:Exploratory Behavior / Q000187:drug effects*; D007490:Iproniazid / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology*; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D012110:Reserpine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000494:pharmacology*; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012702:Serotonin Antagonists; D013566:Sympathomimetics; D014363:Tryptamines; D003533:Cyproheptadine; D012701:Serotonin; D014191:Tranylcypromine; D008694:Methamphetamine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D007490:Iproniazid; D008784:Methysergide